Literature DB >> 12603645

Migraine disability assessment (MIDAS) score: relation to headache frequency, pain intensity, and headache symptoms.

Walter F Stewart1, Richard B Lipton, Ken Kolodner.   

Abstract

OBJECTIVE: To determine the extent to which variation in the Migraine Disability Assessment (MIDAS) score is associated with headache frequency, pain intensity, headache symptoms, gender, and employment status.
BACKGROUND: The MIDAS questionnaire is a 7-item questionnaire (with 5 scored items) designed to measure headache-related disability, to improve physician-patient communication, and to identify patients with high treatment needs.
METHODS: Data from 3 population-based studies (total sample, n = 397) conducted in the United States and the United Kingdom were used to evaluate the relationship between headache features (attack frequency, pain intensity, pain quality, and associated symptoms) and MIDAS score. Data on headache features were collected by telephone using a standardized interview. The MIDAS questionnaire was completed shortly after the telephone interview. General linear models were used to determine the extent to which population variation in the MIDAS score was explained by headache features.
RESULTS: Using linear regression, variables for all headache features (ie, headache frequency, pain intensity, pain quality, and associated symptoms) and demographic characteristics explained only 22% of the variation in MIDAS scores. Almost all (19.9%) the explained variance was accounted for by average pain intensity (12.0%), number of headache days (6.1%), and exacerbation of pain with movement (1.8%). When pain intensity and headache frequency were included in the model, no statistically significant differences in MIDAS scores were observed by gender or employment status. Although explaining only 2.1% of the variance, age was significantly associated with MIDAS scores, with those under 25 years demonstrating higher MIDAS scores than other age groups. No other variables (ie, frequency of occurrence of associated symptoms and other measures of quality of pain) were associated with MIDAS scores.
CONCLUSIONS: Challenges to the utility of the MIDAS as a measure include whether headache-related disability is largely a function of other routine headache features and whether MIDAS is inherently biased based on work status and gender. While the MIDAS score was associated with headache frequency and average pain score, these two headache features explain only a modest proportion of the variation in MIDAS scores. Additionally, gender and work status were not related to MIDAS scores. These findings suggest that the MIDAS score captures information about disability that is not inherent to other headache features and is independent of gender and work status.

Entities:  

Mesh:

Year:  2003        PMID: 12603645     DOI: 10.1046/j.1526-4610.2003.03050.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  26 in total

1.  Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS).

Authors:  L M Bloudek; M Stokes; D C Buse; T K Wilcox; R B Lipton; P J Goadsby; S F Varon; A M Blumenfeld; Z Katsarava; J Pascual; M Lanteri-Minet; P Cortelli; P Martelletti
Journal:  J Headache Pain       Date:  2012-05-29       Impact factor: 7.277

2.  The contribution of pain-related anxiety to disability from headache.

Authors:  Justin M Nash; David M Williams; Robert Nicholson; Peter C Trask
Journal:  J Behav Med       Date:  2006-01-06

3.  Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders.

Authors:  Gülşen Kocaman; Neşe Kahraman; Banu Gürkan Köseoğlu; Başar Bilgiç; Zeliha Matur; Mustafa Ertaş; Yeşim Gülşen; Betül Baykan Baykal
Journal:  Noro Psikiyatr Ars       Date:  2018-07-06       Impact factor: 1.339

4.  Episodic and Chronic Migraine in Primary Care.

Authors:  Nathan P Young; Lindsey M Philpot; Robert A Vierkant; Jordan K Rosedahl; Sudhindra G Upadhyaya; Ann Harris; Jon O Ebbert
Journal:  Headache       Date:  2019-04-29       Impact factor: 5.887

Review 5.  [Integrated headache care network. Kiel Migraine and Headache Center and German National Headache Treatment Network].

Authors:  H Göbel; K Heinze-Kuhn; I Petersen; A Göbel; A Heinze
Journal:  Schmerz       Date:  2013-04       Impact factor: 1.107

6.  Headache Before and After Endoscopic Transsphenoidal Pituitary Tumor Surgery: A Prospective Study.

Authors:  Agnes Andersson; Tobias Hallén; Daniel S Olsson; Dan Farahmand; Ann-Charlotte Olofsson; Eva Jakobsson Ung; Sofie Jakobsson; Henrik Bergquist; Gudmundur Johannsson; Oskar Ragnarsson; Thomas Skoglund
Journal:  J Neurol Surg B Skull Base       Date:  2021-05-29

Review 7.  Migraine headache: options for acute treatment.

Authors:  Frederick R Taylor
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

Review 8.  Treatment of migraine in patients with CADASIL: A systematic review and meta-analysis.

Authors:  Patrick A Glover; Eric D Goldstein; Mohammed K Badi; Tara J Brigham; Elizabeth R Lesser; Thomas G Brott; James F Meschia
Journal:  Neurol Clin Pract       Date:  2020-12

9.  Self-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment, and economic impact.

Authors:  Emina Sokolovic; Franz Riederer; Thomas Szucs; Reto Agosti; Peter Stefan Sándor
Journal:  J Headache Pain       Date:  2013-03-26       Impact factor: 7.277

10.  Headache Impact Test-6 (HIT-6) scores for migraine patients: Their relation to disability as measured from a headache diary.

Authors:  Hae Eun Shin; Jeong Wook Park; Yeong In Kim; Kwang Soo Lee
Journal:  J Clin Neurol       Date:  2008-12-31       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.